Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Filings indexed 2,851 across all filing types
Latest filing 2021-04-27 Notice of Dividend Amou…
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
未来三年股东回报规划(2021年-2023年)
Notice of Dividend Amount Classification · 95% confidence The document is a detailed plan titled 'Future Three-Year Shareholder Return Plan (2021-2023)' issued by the company's board. It outlines the principles, conditions, forms, and decision-making procedures for profit distribution and shareholder returns over a multi-year period. It references relevant laws and regulations, discusses dividend policies, cash and stock dividends, and governance mechanisms related to shareholder returns. There is no indication that this is an announcement of a report publication, nor is it a financial statement or earnings release. It is a formal policy document related to dividend and shareholder return planning, which fits best under the category of Notice of Dividend Amount (DIV) because it deals with dividend policy and shareholder returns planning rather than actual dividend payment announcements or financial results. The document length is 4231 characters, which is substantive and contains detailed policy content, not just a brief announcement or certification. Therefore, the most appropriate classification is DIV with high confidence.
2021-04-27 Chinese
安信证券股份有限公司关于公司2020年内部控制评价报告的核查意见
Audit Report / Information Classification · 95% confidence The document is titled as an internal control self-evaluation report for the year 2020 of Yingkang Life Technology Co., Ltd., with verification opinions from Anxin Securities Co., Ltd., the sponsoring institution. It discusses the internal control environment, control activities, information and communication, and internal supervision, along with the company's governance structure and internal control evaluation. The document is a detailed report on internal control evaluation and verification, not a general annual report or earnings release. It is not a brief announcement or certification but a substantive report with detailed content on internal control assessment. This fits the definition of an Audit Report / Information (AR), which includes audit reports and applied accounting principles and internal control evaluations, excluding full annual reports. Therefore, the document is best classified as AR with high confidence. FY 2020
2021-04-27 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the sixth meeting of the fifth Supervisory Board of Yingkang Life Technology Co., Ltd. It includes approvals of various reports related to the 2020 fiscal year such as the Supervisory Board work report, general manager work report, full annual report and summary, financial statements, internal control self-assessment report, fundraising usage report, profit distribution plan, and other corporate governance matters. The document also mentions that these reports are disclosed separately on the official information disclosure website (cninfo.com.cn). The document is not the annual report itself but a formal announcement of the Supervisory Board's review and approval of these reports and proposals, which will be submitted to the 2020 annual shareholders meeting for further approval. It contains voting results and procedural details of the Supervisory Board meeting. This type of document fits the category of Regulatory Filings (RNS) as it is a regulatory announcement of meeting resolutions and approvals rather than the full annual report or financial statements themselves. The document length (5074 characters) and content support this classification rather than a full Annual Report (10-K) or Management Report (MDA).
2021-04-27 Chinese
关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a change in accounting policy related to the adoption of a new lease accounting standard. It details the reasons for the change, the effective date, the nature of the change, and the approvals by the board and independent directors. It does not contain financial statements or substantive financial data but rather informs stakeholders about the policy change and its expected impact. The document is relatively short (2432 characters) and serves as a formal disclosure rather than a full financial report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for announcements that do not fit other specific categories and are not full reports themselves.
2021-04-27 Chinese
关联交易管理制度(2021年4月)
Governance Information Classification · 95% confidence The document is titled "关联交易管理制度" which translates to "Related Party Transaction Management System". It details the company's policies, principles, decision-making procedures, responsibilities, and compliance related to related party transactions. The content is a governance and compliance document outlining internal rules and procedures for managing related party transactions, including definitions, decision-making processes, disclosure requirements, and responsibilities of various company departments and personnel. There are no financial statements, audit opinions, earnings data, or regulatory announcements. The document is a formal internal governance policy rather than a report or announcement of financial results or corporate actions. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2021-04-27 Chinese
股东大会议事规则(2021年4月)
Governance Information Classification · 95% confidence The document is titled as the "Rules of Procedure for the Shareholders' General Meeting" of 盈康生命科技股份有限公司. It extensively details the procedures, rights, responsibilities, and regulations governing the conduct of shareholders' meetings, including the convening, proposal submission, voting, and post-meeting matters. It does not contain financial statements, audit opinions, earnings data, or management discussion of financial results. Instead, it is a governance document outlining internal rules and processes related to shareholder meetings. Therefore, it fits best under the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2021-04-27 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.